Skip to main content

Table 1 Patient characteristics (at ICU admission and at the start of CytoSorb or CRRT)

From: Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study

Characteristics

CytoSorb (N = 67)

CRRT only (n = 48)

Unadjusted p value

sIPTW-adjusted p value

Demography

 Age, years (Mean, SD)

61.1 (14.7)

68.7 (9.6)

0.001

0.126

 Male, n (%)

37 (55%)

30 (61%)

0.522

0.021

Comorbidity, n (%)

 Any comorbidity

43 (64%)

42 (88%)

0.002

0.601

 Diabetes mellitus type 2

14 (21%)

20 (41%)

0.024

0.778

 Hypertension

23 (34%)

26 (53%)

0.046

0.409

 Coronary heart disease

9 (13%)

8 (16%)

0.667

0.064

 Heart failure (systolic/diastolic)

4 (6%)

10 (20%)

0.030

0.501

 Prior chronic kidney disease

8 (12%)

18 (37%)

0.003

0.002

 Peripheral artery disease

10 (15%)

8 (16%)

0.839

0.021

 Cerebrovascular accident

6 (9%)

3 (6%)

0.577

0.369

 COPD

8 (12%)

10 (20%)

0.233

0.002

Primary diagnosis, n (%)

 Abdominal sepsis

31 (46%)

12 (25%)

0.014

0.870

 Pneumosepsis

14 (21%)

21 (43%)

0.014

0.275

 Urosepsis

2 (3%)

6 (12%)

0.078

0.217

 Cutaneous/arthritis

9 (13%)

3 (6%)

0.182

0.064

 Vascular sepsis

5 (8%)

0

0.024

0.026

 Cerebral sepsis

0

1 (2%)

0.322

0.475

 Sepsis (unknown cause)

6 (9%)

6 (12%)

0.569

0.755

Admission

 Surgical (otherwise medical)

27 (40%)

6 (12%)

< 0.001

0.994

 Days on ICU

9 (2–19)

9 (3–13)

0.783

0.463

Hemodynamics (Mean, SD)

 Lactate at admission

6.4 (5.1)

4.4 (4.4)

0.027

0.421

 Lactate at the start of therapy

6.9 (5.6)

2.9 (3.1)

< 0.001

0.544

 Noradrenaline (μg/kg/min) adm.

0.48 (0.55)

0.29 (0.40)

0.052

0.073

 Noradrenaline (μg/kg/min) Rx

0.96 (0.73)

0.28 (0.36)

< 0.001

0.769

 Total duration noradrenaline (days)

3 (1–5)

3 (1–5)

0.979

0.222

 Duration noradrenaline from Rx (days)

2 (1–3)

1 (0–2)

0.694

0.989

 MAP at admission

73 (19)

74 (20)

0.748

0.418

 MAP at the start of therapy

69 (15)

77 (18)

0.007

0.019

Prognostic scores

 SOFA ICU admission

11.7 (3.3)

11.8 (3.5)

0.907

0.854

 SOFA at the start of treatment

13.8 (2.8)

12.8 (3.2)

0.067

0.239